- Q1 2024 Panbela Therapeutics Inc Earnings Call TranscriptMay 15, 2024€119.4Earnings
- Q4 2023 Panbela Therapeutics Inc Earnings Call TranscriptMar 26, 2024€119.4Earnings
- Q3 2023 Panbela Therapeutics Inc Earnings Call TranscriptNov 09, 2023€119.4Earnings
- Panbela Therapeutics Inc at LD Micro Main Event XVI Conference TranscriptOct 04, 2023
- Q2 2023 Panbela Therapeutics Inc Earnings Call TranscriptAug 10, 2023€119.4Earnings
- Panbela Therapeutics Inc Annual Shareholders Meeting TranscriptMay 25, 2023
- Q1 2023 Panbela Therapeutics Inc Earnings Call TranscriptMay 04, 2023€255.6 (+0.47%)Earnings
- Q4 2022 Panbela Therapeutics Inc Earnings Call TranscriptMar 16, 2023€369 (+6.03%)Earnings
- Panbela Therapeutics Inc Extraordinary Shareholders Meeting TranscriptNov 29, 2022
- Q3 2022 Panbela Therapeutics Inc Earnings Call TranscriptNov 10, 2022Earnings
- Q2 2022 Panbela Therapeutics Inc Earnings Call TranscriptAug 15, 2022Earnings
- Q1 2022 Panbela Therapeutics Inc Earnings Call TranscriptMay 12, 2022Earnings
- Q3 2021 Panbela Therapeutics Inc Earnings Call TranscriptNov 10, 2021Earnings
- Q2 2021 Panbela Therapeutics Inc Earnings Call TranscriptAug 11, 2021Earnings
- Q1 2021 Panbela Therapeutics Inc Earnings Call TranscriptMay 12, 2021Earnings
Q1 2021 Panbela Therapeutics Inc Earnings Call Transcript
Greetings and welcome to Panbela Therapeutics first-quarter 2021 earnings call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, James Carbonara, Hayden IR.
Thank you. And once again, welcome to Panbela's first-quarter 2021 earnings call. With me on the call are Jennifer Simpson, Chief Executive Officer, and Sue Horvath, Chief Financial Officer.
Before I turn the call over to Dr. Simpson, please note that statements made on this call that are not historical facts may be forward-looking statements. Significant risks and uncertainties that could cause actual results to differ from those expressed or implied in the forward-looking statements are detailed in the company's annual report on Form 10-K and supplemented by subsequently filed quarterly reports on Form 10-Q as well as in other reports that the company has filed with the SEC. Any forward-looking statements made on this call are made only as of today's date, and the company does
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)